A global medical device company in Northern Germany faced a critical need to update its product documentation to comply with the new Medical Device Regulation (MDR), replacing the older Medical Device Directive (MDD). Recognizing the potential impact on product registrations, labeling, and post-market activities, they turned to Zamann Pharma Support for assistance. The project involved evaluating all existing technical documentation and formulating an action plan to align those documents with MDR standards.
Zamann Pharma Support not only provided organizational guidance but also delivered hands-on support by completing the required document updates. This end-to-end approach ensured a smoother transition for the client’s product portfolio, helping the company maintain compliance and avoid regulatory setbacks.
“Zamann Pharma Support guided us effectively through the challenging transition from MDD to MDR. Their ability to manage both the organizational side and hands-on documentation updates was invaluable. We not only met our regulatory deadlines but also improved the overall quality of our technical documentation. Having an integrated approach helped us stay focused on delivering reliable medical devices without compromising on compliance.”